S. Nesterovich (Tomsk, Russian Federation), A. Anzueto (San Antonio, United States of America), G. Rohde (Maastricht, The Netherlands), T. Wilkinson (Southampton, United Kingdom)
LATE-BREAKING ABSTRACT: Distinct bacterial species: Escherichia coli and staphylococcus aureus have specific microcalorimetric patterns
A. Steriade, D. Zaharia, A. Muntean, O. Balint, M. Bogdan, M. Popa, V. Popa (Bucharest, Romania)
|   |
LATE-BREAKING ABSTRACT: Induction of protective T cell immunity against influenza using a novel peptide vaccine
T. Wilkinson, O. Pleguezuelos, S. Robinson, G. Stoloff, R. Lambkin- Williams, J. Oxford, A. Mann, A. Gilbert, W. Caparros-Wanderley (Southampton, London, United Kingdom)
| |
Limited effect of clarithromycin in non-elderly, non-severe patients with influenza
H. Ishii, K. Komiya, H. Kushima, H. Oka, H. Mukae, J.I. Kadota (Yufu, Kitakyushu, Japan)
| |
Incidence of adenoviral infections in children
T. Ilievska, G. Popova (Skopje, Fyrom)
| |
Pulmonary cytomegalovirus infections following renal transplantation
V. Pencheva, D. Petrova, O. Georgiev (Sofia, Bulgaria)
| |
Respiratory functional status after intrapleural t-PA administration for complicated parapneumonic effusions
D. Spyratos, M. Sionidou, M. Antoniou, T. Kontakiotis, K. Zarogolidis, L. Sichletidis (Thessaloniki, Greece)
| |
Nitrofurantoin-induced interstitial lung disease
S. Basunaid, M. Schoutteten, H. Pilate, R. Sprooten, G. Rohde (Maastricht, Netherlands)
| |
Health care associated pneumonia versus community acquired pneumonia: Comparison of etiology, treatment and prognosis
C. Araujo, N. Andre, P. Raimundo, A. Domingos (Torres Vedras, Portugal)
| |
Clinical features, outcome and factors associated with mortality in patients with Nocardia pneumonia
I. Muhammad, A.S. Haque, K. Jabeen, W. Hafiz Abdul, S. Awan, F. Ur Rehman (Karachi, Karach, Pakistan)
| |
Local and systemic cytokine profiles in patients with non-severe and severe community-acquired pneumonia
M. Paats, I. Bergen, W. Hanselaar, C. Groeninx van Zoelen, H. Hoogsteden, R. Hendriks, M. van der Eerden (Rotterdam, Netherlands)
| |
Acute respiratory distress syndrome (ARDS) – Manifestation of onset in an immunocompetent patient with pleuropulmonary tuberculosis (TB)
E. Tabacu, R. Nemes, L. Puiu, M. Mitrea, N. Galie (Bucharest, Baia Mare, Romania)
| |
Endothelial damage markers in patients with pandemic influenza A (H1N1/09)
S. Lukyanov, A. Govorin, V. Gorbunov, E. Romanova (Chita, Russian Federation)
| |
The clinical evaluation of respiratory tract infection caused by MRSA
K. Nakashima, Y. Otsuka, H. Kobayashi, N. Katsurada, N. Asai, H. Makino, M. Misawa, Y. Ohkuni, N. Kaneko, M. Aoshima (Kamogawa, Japan)
| |
Pulmonary effects of perfluorocarbon emulsion therapy on Streptococcus pneumoniae infection in sickle cell mice
N. Helmi, P. Andrew, H. Pandya (Leicester, United Kingdom)
| |
What happens to pneumocystis prophylaxis use when antiretroviral therapy is widely available?
S. Capocci, C. Smith, N. Marshall, R. Tsintas, F. Thomas, M. Tyrer, M. Johnson, M. Lipman (London, United Kingdom)
| |
Community-acquired pneumonia during the influenza pandemic A(H1N1)pdm09 and post-pandemic period in hospitalized patients, Russia
Z. Bobyleva, I. Leshchenko, N. Ponamareva, Y. Morozova, A. Plotnicova (Yekaterinburg, Russian Federation)
| |
Prevention of the recurrent acute respiratory viral infections in children
A. Zaplatnikov, N. Korovina, I. Zakharova, E. Burtseva, G. Mingalimova, L. Zaplatnikova, I. Zak, L. Shamrai (Moscow, Russian Federation)
| |
Prevalence and risk factors for pneumonia in a cohort with clinical suspicion of influenza A (H1N1)
M. Serra, S. Capilla, G. Navarro, E. Monsó, C. Grimau, M. Gallego (Sabadell, Spain)
| |
Nebulised therapy in pregnants with acute respiratory virus infections (ARVI)
J. Pahomova, D. Ashurova, R. Hayaliev (Tashkent, Uzbekistan)
| |
Application of dot immunoenzyme filtration assay for rapid detection of influenza A virus
Y.X. Tan, C. Chen, X. Jie, K. Cao (Guangzhou, China)
| |